Assuming 30 trading days horizon, Insite Vision Inc. is expected to generate 0.98 times more return on investment than Generex. However, Insite Vision Inc. is 1.02 times less risky than Generex. It trades about -0.01 of its potential returns per unit of risk. Generex Biotechnology Corporation is currently generating about -0.07 per unit of risk. If you would invest 37.00 in Insite Vision Inc. on April 26, 2012 and sell it today you would lose (2.00) from holding Insite Vision Inc. or give up 5.41% of portfolio value over 30 days.
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Insite Vision Inc. and Generex Biotechnology Corp. in the same portfolio (assuming nothing else is changed)